1 Min Read
Nov 1 (Reuters) - United Neuroscience `
* United Neuroscience presents data for Phase 2 active vaccine program UB-311 at the clinical trials on alzheimer’s disease 2017 meeting Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.